Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ Agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia

Yan Chen, Hongmei Chen, Yochai Birnbaum, Manjyot K. Nanhwan, Mandeep Bajaj, Yumei Ye, Jinqiao Qian

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ Agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Keyphrases